Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012277
Filing Date
2022-08-04
Accepted
2022-08-04 16:58:56
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20220630x10q.htm   iXBRL 10-Q 1946071
2 EX-31.1 ptgx-20220630xex31d1.htm EX-31.1 10122
3 EX-31.2 ptgx-20220630xex31d2.htm EX-31.2 10146
4 EX-32.1 ptgx-20220630xex32d1.htm EX-32.1 9505
5 GRAPHIC ptgx-20220630x10q007.jpg GRAPHIC 104214
  Complete submission text file 0001558370-22-012277.txt   7844843

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20220630.xsd EX-101.SCH 54220
7 EX-101.CAL ptgx-20220630_cal.xml EX-101.CAL 48351
8 EX-101.DEF ptgx-20220630_def.xml EX-101.DEF 231074
9 EX-101.LAB ptgx-20220630_lab.xml EX-101.LAB 413835
10 EX-101.PRE ptgx-20220630_pre.xml EX-101.PRE 357578
63 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20220630x10q_htm.xml XML 1365180
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 221137537
SIC: 2834 Pharmaceutical Preparations